Knowledge Network Node

海翔药业拟募资5亿布局下游 华夏与嘉实四季度加仓被套

徐锐

Snapshot of full-text:
在4-AA中间体、原料药等产品上颇具传统优势的海翔药业,如今则有意借道定向增发融资布局下游制剂产业,以期实现业绩“双轮驱动”的构想。   停牌四天后,海翔药业定向增发预案今日出炉。公司拟以20.92元/股的发行底价向不超过十名特定对象定向发行不超过2500万股,募资?
Newspaper Date:

2011-02-25

Edition No:

公司

Edition Code:

F07

  • Series:

    (J) Economics & Management

  • Subject:

    Finance; Securities; Investment

  • Classification Code:

    F832.51

Download the mobile appuse the app to scan this coderead the article.

Tips: Please download CAJViewer to view CAJ format full text.

Download: 31 Pagecount: 1 Size: 11k

Related Literature
  • Similar Article
  • Readers' Recommendations
  • Associated Author